You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastatic Pancreatic Ductal Adenocarcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Pancreatic Ductal Adenocarcinoma Trial in Washington (BXCL701, Pembrolizumab)

Not yet recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Jan 23, 2023

Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in New

Recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • +12 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 30, 2022

Metastatic Pancreatic Cancer Trial in Washington (Gemcitabine, Nab paclitaxel, Proglumide Dose level 1)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center, Georgetown University
Apr 11, 2023

Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Durvalumab
  • Rintatolimod
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus MC
Jun 23, 2023

Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Seattle (Autologous Mesothelin-specific

Recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Stage IV Pancreatic Cancer AJCC v8
  • Autologous Mesothelin-specific TCR-T Cells
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 31, 2023

Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma Trial in Washington (Eryaspase,

Active, not recruiting
  • Locally Advanced Pancreatic Ductal Adenocarcinoma
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Aug 3, 2022

Pancreatic Ductal Adenocarcinoma Trial in United States (Onvansertib, Nanoliposomal irinotecan, Leucovorin)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Phoenix, Arizona
  • +5 more
Dec 15, 2022

Metastatic Pancreatic Cancer Trial in Washington (Gemcitabine, Nab paclitaxel, Proglumide Dose level 1)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center, Georgetown University
Aug 24, 2023

CYP3A Inhibitor, Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma Trial in Heidelberg (Cobicistat Oral Tablet)

Not yet recruiting
  • CYP3A Inhibitor
  • Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma
  • Cobicistat Oral Tablet
  • Heidelberg, BW, Germany
    University Hospital Heidelberg
Aug 10, 2022

Pancreatic Ductal Adenocarcinoma Trial in Miami (Trametinib, Ruxolitinib, Retifanlimab)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Miami, Florida
    University of Miami
Jun 27, 2022

Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

Not yet recruiting
  • Pancreatic Acinar Cell Carcinoma
  • +6 more
  • Nab paclitaxel
  • +5 more
  • (no location specified)
Oct 30, 2023

Pancreas Cancer Trial in Seoul (Vactosertib)

Recruiting
  • Pancreas Cancer
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With

Recruiting
  • Pancreatic Cancer
  • +4 more
  • PET Scan
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 10, 2023

Untreated Metastatic Pancreatic Ductal Adenocarcinoma Trial in Scottsdale (Nivolumab, Albumin-bound paclitaxel, Paricalcitol)

Active, not recruiting
  • Untreated Metastatic Pancreatic Ductal Adenocarcinoma
  • Scottsdale, Arizona
    HonorHealth Research Institute
Feb 15, 2022

RWE on mPDAC Long-term Survival After Treatment With Liposomal

Recruiting
  • Pancreatic Cancer Metastatic
    • Munich, Germany
      Klinikum der Universität München, - Anstalt des öffentlichen Rec
    Nov 24, 2023

    Metastatic Pancreatic Ductal Adenocarcinoma Trial in France, Spain (CAN04, FOLFIRINOX)

    Recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • Bordeaux, France
    • +7 more
    May 16, 2022

    Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC

    Recruiting
    • Locally Advanced Pancreatic Ductal Adenocarcinoma
    • +7 more
    • Gemcitabine Hydrochloride
    • +8 more
    • Philadelphia, Pennsylvania
    • +1 more
    Dec 20, 2022

    Metastatic Pancreatic Ductal Adenocarcinoma Trial in Belgium (Nanoliposomal irinotecan, 5 FU, Leucovorin)

    Recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • Nanoliposomal irinotecan
    • +3 more
    • Brugge, West-Vlaanderen, Belgium
    • +11 more
    Jul 25, 2022

    Metastatic Pancreatic Cancer Trial in Seoul (TEW-7197)

    Recruiting
    • Metastatic Pancreatic Cancer
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jun 13, 2022

    Metastatic Pancreatic Ductal Adenocarcinoma Trial in United States (Relacorilant, 100 mg and 25 mg, Nab paclitaxel)

    Terminated
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • Relacorilant, 100 mg and 25 mg
    • Nab paclitaxel
    • Scottsdale, Arizona
    • +17 more
    May 11, 2022

    Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Trial in Rochester (SX-682, Nivolumab Injectable Product)

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • Pancreatic Cancer
    • SX-682
    • Nivolumab Injectable Product
    • Rochester, New York
      University of Rochester
    Dec 14, 2021

    Metastatic Pancreatic Ductal Adenocarcinoma Trial in Belgium, France, Spain (CD40 agonist mitazalimab in combination with chemo)

    Recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • CD40 agonist mitazalimab in combination with chemotherapy
    • Brussels, Belgium
    • +15 more
    Aug 12, 2022

    Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)

    Recruiting
    • Pancreatic Adenocarcinoma Metastatic
    • +14 more
    • Boston, Massachusetts
    • +1 more
    Dec 6, 2022

    Pancreatic Cancer Trial (CEND-1)

    Not yet recruiting
    • Pancreatic Cancer
    • (no location specified)
    Sep 13, 2021

    Metastatic Pancreatic Ductal Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 Trial

    Not yet recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • +3 more
    • Biopsy
    • +8 more
    • (no location specified)
    Jan 13, 2023